Filing Flows › Abbott Laboratories (ABT) › Q2 2025
Abbott Laboratories (ABT) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 30, 2025
Abbott Laboratories (ABT) reported revenue of $11.1B for the second quarter 2025 (Q2 2025), +7% from a year earlier and +8% from the quarter before. Operating margin was 18.4%, net earnings $1.8B (16.0% of revenue).
Abbott Laboratories, Q2 2025: revenue $11.1B (+7% year over year), operating margin 18.4%, net earnings $1.8B, operating cash flow $2.0B. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.1B | +8% | +7% |
| Operating profit | $2.1B | +21% | +23% |
| Net earnings | $1.8B | +34% | +37% |
| Operating cash flow | $2.0B | +44% | +4% |
| Free cash flow | $1.5B | +66% | +8% |
What changed
Revenue was $11.1B in Q2 2025, up 7% year over year and up 8% from the previous quarter.
Operating profit was $2.1B, a 18.4% margin (up 2.3 points year over year). Of the extra revenue versus a year earlier, 50% reached operating profit, above the 16% margin then. Total costs grew 4% against revenue growth of 7%. Net earnings were $1.8B, up 37% year over year. The effective tax rate was 17.3%.
Operating cash flow was $2.0B (up 4% year over year), 115% of net earnings. Non-cash charges added back $0.78B of depreciation and amortization and $0.14B of share-based compensation. Working capital and other items used $0.65B. Capital expenditures of $0.50B left free cash flow of $1.5B.
Questions
What was Abbott Laboratories' revenue in the second quarter 2025?
Abbott Laboratories (ABT) reported revenue of $11.1B for the second quarter 2025 (Q2 2025), +7% from a year earlier and +8% from the quarter before.
Was Abbott Laboratories profitable in the second quarter 2025?
Operating profit was $2.1B (18.4% of revenue) and net earnings $1.8B.